Literature DB >> 9030871

Different Trypanosoma cruzi strains promote neuromyopathic damage mediated by distinct T lymphocyte subsets.

G A Mirkin1, A M Celentano, E L Malchiodi, M Jones, S M González Cappa.   

Abstract

The proliferative response of CD4 and CD8 T lymphocytes obtained from C3H/HeN mice chronically infected with Trypanosoma cruzi strains that differ in virulence, tropism and immunogenicity, was assayed against skeletal muscle, sciatic nerve and spinal cord homogenates. Although both CD4 and CD8 T lymphocytes from mice infected with the RA strain strongly proliferated against the nervous system, no response against skeletal muscle antigens was detected. CD4 and CD8 T lymphocytes from mice infected with the K-98 clone (from CA-I strain) showed low proliferative response against all the antigens assayed. To determine whether the proliferation patterns showed correlation with T cell-mediated neuromuscular damage, passive cell transfer studies were performed. Fifteen days after transfer of CD4 T cells from RA-infected donors (CD4-RA), normal syngeneic recipients displayed exclusively nervous tissue damage, such as perineural, endoneural and/or meningeal inflammatory infiltrates, with predominance of CD4 T cells. Fifteen days after transfer of CD4 T lymphocytes from mice infected with K-98 (CD4-K98), recipients showed inflammatory infiltrates only in skeletal muscle, where CD4 T lymphocytes and macrophages were predominant cells. Recipients of CD8 T cells from RA-infected mice (CD8-RA) showed lesions in both spinal cord and sciatic nerves. Higher percentages of CD8 T cells were observed in comparison with the recipients of CD4-RA or CD4-K98. In contrast, CD8 T cells from K-98-infected donors (CD8-K98) did not induce tissue damage. These results provide evidence that mice infected with T. cruzi populations that differ in their biological characteristics show diverse immune mechanisms that may be involved in the pathogenesis of peripheral nervous system damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030871      PMCID: PMC1904581          DOI: 10.1111/j.1365-2249.1997.267-ce1166.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Authors:  Silvia I Cazorla; Pablo D Becker; Fernanda M Frank; Thomas Ebensen; María J Sartori; Ricardo S Corral; Emilio L Malchiodi; Carlos A Guzmán
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

2.  Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner.

Authors:  Catalina D Alba Soto; Gerardo A Mirkin; Maria E Solana; Stella M González Cappa
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.

Authors:  Ágata C Cevey; Gerardo A Mirkin; Martín Donato; María J Rada; Federico N Penas; Ricardo J Gelpi; Nora B Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-07       Impact factor: 4.077

4.  Different genotypes of Trypanosoma cruzi produce distinctive placental environment genetic response in chronic experimental infection.

Authors:  Natalia Anahí Juiz; María Elisa Solana; Gonzalo Raúl Acevedo; Alejandro Francisco Benatar; Juan Carlos Ramirez; Priscilla Almeida da Costa; Andrea Mara Macedo; Silvia Andrea Longhi; Alejandro G Schijman
Journal:  PLoS Negl Trop Dis       Date:  2017-03-08

5.  Immunophenotypic lymphocyte profiles in human african trypanosomiasis.

Authors:  Caroline Boda; Bertrand Courtioux; Pierre Roques; Lynda Pervieux; Gédéon Vatunga; Théophile Josenando; Constant Roger Ayenengoye; Bernard Bouteille; Marie-Odile Jauberteau; Sylvie Bisser
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

Review 6.  Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy.

Authors:  Santiago J Martinez; Patricia S Romano; David M Engman
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 6.073

7.  Neuronal Parasitism, Early Myenteric Neurons Depopulation and Continuous Axonal Networking Damage as Underlying Mechanisms of the Experimental Intestinal Chagas' Disease.

Authors:  Mayra Fernanda Ricci; Samantha Ribeiro Béla; Michele Macedo Moraes; Maria Terezinha Bahia; Ana Lia Mazzeti; Anny Carolline Silva Oliveira; Luciana Oliveira Andrade; Rafael Radí; Lucía Piacenza; Rosa Maria Esteves Arantes
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.